Can an elevated fasting glucose with a normal HbA1c reflect episodic glucose spikes?

Discordance between fasting plasma glucose (FPG) and Hemoglobin A1c (HbA1c) is a well-documented clinical phenomenon. Because these two biomarkers measure glucose metabolism over different timeframes and through different physiological mechanisms, it is entirely possible to have an elevated fasting glucose level while maintaining a "normal" HbA1c.

Clinical and effectiveness evidence

The presentation of elevated FPG (typically 100–125 mg/dL) alongside a normal HbA1c (<5.7%) is a recognized clinical phenotype known as isolated Impaired Fasting Glucose (IFG).

• Phenotypic prevalence: Research from large-scale studies like NHANES suggests that approximately 20% to 30% of individuals categorized with prediabetes meet the criteria for elevated FPG but not for elevated HbA1c.
• Temporal sensitivity: FPG is a "snapshot" measurement sensitive to acute factors from the previous 8–12 hours, such as recent stress, poor sleep, or a high-carbohydrate late-night meal. In contrast, HbA1c is a weighted average of blood glucose over the preceding 90 to 120 days.
• Diagnostic limitations: HbA1c has relatively low sensitivity for detecting short-term glucose variability. It requires a sustained increase in the total "glucose area under the curve" (AUC) over several weeks to reflect a significant upward shift.

Mechanistic explanations

The discrepancy between these markers is rooted in how glucose interacts with red blood cells and how the liver manages energy during sleep.

• Glycation kinetics: HbA1c forms through a slow, non-enzymatic glycation process where glucose molecules bond to hemoglobin. This follows first-order kinetics, meaning the rate of HbA1c formation is proportional to the average glucose concentration over time. Isolated or infrequent spikes do not provide a sufficient "glucose-time integral" to significantly alter this 3-month average.
• Hepatic insulin resistance: An elevated FPG specifically reflects increased nocturnal hepatic glucose production (the liver releasing too much sugar overnight) or impaired suppression of this production by insulin.
• Reversibility: Early stages of glycation (labile HbA1c) are reversible. Glucose spikes must be sustained or highly frequent for the glycation to become the stable, irreversible form measured in standard laboratory tests.

Bottom line

An elevated fasting glucose with a normal HbA1c is a plausible indicator of early metabolic shifts, such as hepatic insulin resistance or recent episodic glucose spikes. Because HbA1c is a long-term average, it often fails to capture infrequent or short-lived glycemic excursions that may still be high enough to trigger an abnormal fasting result.